FINANCIALS

TAK Takeda Pharmaceutical Co Ltd 1395064

Income Statement
Revenue	form6k_121824	4,263,762,000,000
Net Income	form6k_121824	144,197,000,000
Profit Margin		3.38%

Balance Sheet
Current Assets	2,558,580,000,000
Assets	15,108,792,000,000
Current Liabilities	2,313,103,000,000
Liabilities	7,834,787,000,000
Equity	7,274,005,000,000
Shares Out	1,590,938,000

Cash Flow Statement
Operating Cash Flow	716,344,000,000
Investing Cash Flow	-463,862,000,000

Market Analysis
Market Cap	47,018,675,234
Price	12.92
BVPS	4572.15
EPS	0.33
PE	44.60
FCF	252,482,000,000

Dividends

Dividend Amount

0.29

Dividend Yield

2.13%

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view TAK documents filed with the SEC.

TAK Filings Clear

View A List of Tickers